You are here Home India Operations

Intas is one of the fastest growing Indian pharmaceutical majors, having 2.64% share and 19.4% growth rate (as per Feb' 15 MAT). Currently ranked at 11th , its focus on super-specialty in Central Nervous System (CNS), Nephrology, Gastroenterology, Urology, Orthopedics & Cardiology-Diabetics segments has empowered its rapid ascendancy.

Intas has employed a therapy centric business model for the Indian market and has emerged as a strong competitor. The domestic business contributes to about 60% of the total revenue. The current emphasis is on Central Nervous System (CNS), Cardiovascular, Diabetology, Gastroenterology, Urology and Pain Management therapies. While Intas enjoys leadership status (2nd) in the CNS segment, it has also forayed into Dermatology, Gynecology and Respiratory segments.

Intas operates through 33 exclusive and dedicated sales depots and has established relationships with over 4100 stockists in India. A dedicated sales representative team of 3000+ covers more than 1,50,000 doctors including specialists from different therapy areas. The company is set to enhance its presence in the market through its active progress in NDDS. Currently, Intas has launched 3 NDDS products in India using patented technology.